Medscape Hematology-Oncology Headlines

Bendamustine: A New Treatment Option for Chronic Lymphocytic Leukemia

Wed, 25 Nov 2009 12:00:00 EST

Learn more about the first new FDA-approved treatment for chronic lymphocytic leukemia in 7 years.

Lifestyle Interventions in the Prevention and Treatment of Cancer

Wed, 25 Nov 2009 12:00:00 EST

Certain lifestyle factors continue to be causally related to certain cancers, and other cancers have lifestyle-based etiologic factors. Lifestyle changes and cancer prevention/treatment are discussed.

New Director for National Human Genome Research Institute

Tue, 24 Nov 2009 23:58:30 EST

Eric D. Green, MD, PhD, has been named to the NHGRI director post by predecessor and current NIH director Francis S. Collins, MD, PhD.

Two More Cancer Drugs Refused By UK NICE

Tue, 24 Nov 2009 14:16:02 EST

The United Kingdom has decided that the use of sorafenib for liver cancer is not cost-effective, a decision out of step with the rest of Europe.

How Do PSA Level and Kinetics Affect Tumor Detection by 11C-Choline PET/CT in Men With Biochemical Relapse After Radical Prostatectomy?

Tue, 24 Nov 2009 11:34:15 EST

Commentary on a study on the effect of total PSA, PSA velocity, and PSA doubling time on the 11C-choline PET/CT detection rate in men with PSA relapse after radical prostatectomy.

Chemotherapy for Stage 4 NSCLC -- New Update to ASCO Guidelines

Tue, 24 Nov 2009 08:40:30 EST

New recommendations, added to guidelines that were last updated in 2003, include details of when to use targeted therapies.

Novel Biomarkers May Enhance Cancer Therapy

Mon, 23 Nov 2009 16:43:34 EST

Scientific advances are producing potential new biomarkers that help predict response to cancer therapeutics, and thus individualize treatment and improve outcomes.

Ultrasound-Assisted Thrombolysis Improves Outcomes in Chronic DVT

Mon, 23 Nov 2009 14:56:41 EST

Aggressive intervention in chronic DVT using ultrasound-assisted thrombolysis shows superior outcomes compared with non-ultrasound-assisted thrombolysis, according to registry data.

AACR-NCI-EORTC 2009 International Conference on Molecular Targets and Cancer Therapeutics

Mon, 23 Nov 2009 11:40:59 EST

Read clinically focused news coverage of key developments from the meeting.

Skin Cancer in Skin of Color

Mon, 23 Nov 2009 12:00:00 EST

In this review, differences in risk factors, clinical presentation, and mortality in non-white populations are examined.

ACOG Issues Revised Cervical Cancer Screening Guidelines

Fri, 20 Nov 2009 16:08:08 EST

Revised American College of Obstetricians and Gynecologists guidelines now recommend first cervical cancer screening at age 21 years and less frequent rescreening.

Investigators Point to Unethical Reporting in Gabapentin Studies

Fri, 20 Nov 2009 14:47:46 EST

Internal company documents obtained during litigation suggest Pfizer influenced outcomes in published trials, report researchers.

Sen Grassley Questions Top Medical Schools About Ghostwriting

Fri, 20 Nov 2009 13:48:39 EST

As part of his mission to see more financial transparency in medicine, Sen Grassley has asked eight top US medical schools about their policies on ghostwriting.

Intensity-Modulated Radiotherapy Promising for Cervical Cancer

Fri, 20 Nov 2009 12:53:15 EST

This approach can decrease treatment-related toxicity and might improve outcomes in cervical cancer.

New Creative Approaches to Pancreatic Cancer Improve Drug Delivery

Fri, 20 Nov 2009 08:45:34 EST

Pancreatic cancer remains the deadliest of cancer, but new approaches that improve the delivery of drugs to the tumor appear to hold promise.

House Passes Medicare SGR Fix

Thu, 19 Nov 2009 17:11:22 EST

The House passed a bill that would rewrite the controversial sustainable growth rate formula and eliminate a 21.2% Medicare pay cut for physicians scheduled for 2010.

Patients and Doctors Differ When Reporting Adverse Events

Thu, 19 Nov 2009 14:20:58 EST

Although clinician and patient reporting of treatment-related adverse effects differ from each another, together they are complementary and provide a more complete picture.

Aggressive Treatment of Ovarian Cancer Not Supported By Science

Thu, 19 Nov 2009 12:09:29 EST

A survey designed to collect information on practice patterns of physicians treating women at high risk for ovarian cancer shows an increase in the aggressiveness of treatment in the past 7 years.

New Breast Cancer Screening Guidelines Opposed by Societies

Thu, 19 Nov 2009 11:35:47 EST

The ACS, ACR, and ACOG advocate continuing to follow their own current guidelines and not adopting the new USPSTF recommendations.

Primary Amelanotic Malignant Melanoma of the Esophagus

Thu, 19 Nov 2009 09:47:38 EST

A case of primary amelanotic malignant melanoma of the esophagus that presented as an esophageal mass in a 66-year-old woman is discussed.